Clostridium difficile infection and fecal microbiota transplantation

Abstract

Recurrent Clostridium difficile infection (CDI) is the very intensive problems in America and Europe. This infection causes high mortality, poor health and loss of time and property. There are several methods using for recovery from the infection such as new antibiotics testing, probiotics using and surgery including medication, but the results are not satisfactory. Fecal microbiota transplantation (FMT), the traditional wisdom of the Chinese people used to treat diarrhea or severe inflammatory bowel, is the one of alternative method to treat this infection. This method results in high recovery rate from recurrent CDI with no complications from treatment. Currently, the United States FDA has determined that in the cases of standard treatment is not effective, FMT is the drug and biological product which intended for using in the patients with recurrent C. difficile infection.